Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more...
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e52d965976c1e0c2f8d89ccb548a2577.jpg"/><p>Novo Nordisk just cut the price of i [...]
Elon Musk is reportedly trying to take SpaceX public
<p>Elon Musk is reportedly looking to finally take SpaceX public after years of resistance, according to sources who spoke to <a data-i13n="elm:affiliate_link;sellerN:The Wall Street Jou [...]